Earnings (Loss) Per Share

9 Months Ended

Feb. 28, 2025

EARNINGS (LOSS) PER SHARE

The following table summarizes the reconciliation of the numerators and denominators for the basic and diluted earnings (loss) per share computation for the periods indicated:


	Three months ended				Nine months ended
	February 28,		February 29,		February 28,		February 29,
	2025		2024		2025		2024
Net income (loss) attributable to Class A and Common Stockholders	$	(3.6)	$	(26.5)	$	(17.3)	$	(23.8)
Weighted average Shares of Class A Stock and Common Stock outstanding for basic earnings (loss) per share (in millions)		27.8		29.1		28.1		29.9
Dilutive effect of Common Stock potentially issuable pursuant to stock-based compensation plans (in millions)*		—		—		—		—
Adjusted weighted average Shares of Class A Stock and Common Stock outstanding for diluted earnings (loss) per share (in millions)		27.8		29.1		28.1		29.9
Earnings (loss) per share of Class A Stock and Common Stock:
Basic	$	(0.13)	$	(0.91)	$	(0.61)	$	(0.80)
Diluted	$	(0.13)	$	(0.91)	$	(0.61)	$	(0.80)
Anti-dilutive shares pursuant to stock-based compensation plans*		1.9		1.1		1.7		0.7

* The Company experienced a net loss for the three and nine months ended February 28, 2025 and therefore did not report any dilutive share impact. The following potential common shares were excluded from the loss per diluted share computation: outstanding options and restricted stock units of 2.7 million and 0.5 million, respectively.

The following table sets forth options outstanding pursuant to stock-based compensation plans as of the dates indicated:


	February 28, 2025	February 29, 2024
Options outstanding pursuant to stock-based compensation plans (in millions)	2.7	3.0

As of February 28, 2025, $46.6 remained available for future purchases of common shares under the repurchase authorization of the Board of Directors (the "Board") in effect on that date. See Note 12, "Treasury Stock", for a more complete description of the Company’s share buy-back program and Note 18, "Subsequent Events" for additional Board authorization for common share repurchases.